Kobayashi Takao, Sugiura Kazuko, Ojima Toshiyuki, Serizawa Mariko, Hirai Kyuya, Morishita Eriko
Department of Obstetrics and Gynecology, Hamamatsu Medical Center, 328 Tomitsuka-Cho, Chuo-Ku, Hamamatsu, Shizuoka, 432-8580, Japan.
Faculty of Nursing, Department of Women's Health, Nursing and Midwifery, Fukuoka Prefectural University, 4395 Ita, Tagawa, Fukuoka, 825-8585, Japan.
Thromb J. 2024 Feb 8;22(1):18. doi: 10.1186/s12959-024-00581-z.
We previously conducted a primary survey of pregnant women with hereditary thrombophilia based on national surveillance in Japan, but did not examine their thrombosis-related characteristics. Antithrombin (AT) deficiency, protein C (PC) deficiency and protein S (PS) deficiency are the major types of hereditary thrombophilia in Japan.
We examined their detailed information related to thrombosis, and evaluated peripartum outcomes in comparison with control data obtained from the Japan Society of Obstetrics and Gynecology.
Definite or probable AT deficiency, PC deficiency and PS deficiency were observed in 80, 50, and 317 pregnancies, respectively, from 2014 to 2018 in Japan, with prevalence rates among total deliveries of 0.011%, 0.007%, 0.044%. The number of pregnancies with AT, PC and PS deficiency might have been as many as 27, 17 and 108 every year if complete answers had been provided. In the peripartum period of current pregnancies, 27.5% of women with AT deficiency, 28.0% with PC deficiency and 13.2% with PS deficiency developed thrombosis (p < 0.001 vs. control). Pregnant women with AT and PC deficiency were more susceptible to thrombosis than those with PS deficiency (P < 0.01). Of the thromboses, 92.3% occurred during pregnancy, 62.8% at less than 15 gestational weeks. The earliest onset of thrombosis was 5 gestational weeks. Prophylactic anticoagulation significantly prevented the onset of both antepartum and postpartum thrombosis (p < 0.0001). The rate of recurrent pregnancy loss in women with low PC or PS activities was significantly higher than in controls (p < 0.0001); however, it is unknown whether recurrent pregnancy loss is related to hereditary PS deficiency. There seem to have been few serious maternal or fetal/neonatal complications due to placental insufficiency related to a hypercoagulable state other than growth restriction.
This survey revealed the thrombosis-related characteristics of pregnant women with hereditary thrombophilia in Japan. We suggest prophylactic anticoagulation to prevent maternal or fetal/neonatal complications.
我们之前基于日本的全国监测对患有遗传性血栓形成倾向的孕妇进行了初步调查,但未研究她们与血栓形成相关的特征。抗凝血酶(AT)缺乏症、蛋白C(PC)缺乏症和蛋白S(PS)缺乏症是日本遗传性血栓形成倾向的主要类型。
我们研究了她们与血栓形成相关的详细信息,并与从日本妇产科学会获得的对照数据进行比较,评估围产期结局。
2014年至2018年期间,在日本分别有80例、50例和317例妊娠被观察到明确或可能的AT缺乏症、PC缺乏症和PS缺乏症,在总分娩数中的患病率分别为0.011%、0.007%、0.044%。如果能得到完整回复,每年患有AT、PC和PS缺乏症的妊娠数可能分别多达27例、17例和108例。在当前妊娠的围产期,AT缺乏症女性中有27.5%、PC缺乏症女性中有28.0%、PS缺乏症女性中有13.2%发生了血栓形成(与对照组相比,p < 0.001)。患有AT和PC缺乏症的孕妇比患有PS缺乏症的孕妇更容易发生血栓形成(P < 0.01)。在发生的血栓形成中,92.3%发生在孕期,62.8%发生在妊娠15周之前。血栓形成最早发生在妊娠5周。预防性抗凝显著预防了产前和产后血栓形成的发生(p < 0.0001)。PC或PS活性低的女性复发性流产率显著高于对照组(p < 0.0001);然而,复发性流产是否与遗传性PS缺乏症有关尚不清楚。除了生长受限外,似乎很少有因高凝状态相关的胎盘功能不全导致的严重母体或胎儿/新生儿并发症。
这项调查揭示了日本患有遗传性血栓形成倾向的孕妇与血栓形成相关的特征。我们建议进行预防性抗凝以预防母体或胎儿/新生儿并发症。